Reaction

Retinal Vein Thrombosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 697 reports · 7 co-occurring drugs

As of the last recalculation, Retinal Vein Thrombosis appears in 697 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is RALOXIFENE HYDROCHLORIDE (PRR 119.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Raloxifene Hydrochloride54119.6120.1
Romiplostim612.012.0
Fremanezumab-Vfrm410.510.5
Aflibercept109.79.7
Ranibizumab89.19.1
Drospirenone And Ethinyl Estradiol117.57.5
Levonorgestrel223.33.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.